These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4728328)

  • 1. The disposition of propranolol. IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver.
    Evans GH; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1973 Sep; 186(3):447-54. PubMed ID: 4728328
    [No Abstract]   [Full Text] [Related]  

  • 2. The disposition of propranolol. VII. The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver.
    Shand DG; Branch RA; Evans GH; Nies AS; Wilkinson GR
    Drug Metab Dispos; 1973; 1(5):679-86. PubMed ID: 4149706
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic uptake of propranolol.
    Anderson JH; Anderson RC; Iben LS
    J Pharmacol Exp Ther; 1978 Jul; 206(1):172-80. PubMed ID: 660547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver.
    Branch RA; Nies AS; Shand DG
    Drug Metab Dispos; 1973; 1(5):687-90. PubMed ID: 4149707
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo study of propranolol and metabolite(s) disposition in rat liver.
    Ong H; du Souich P; Marchand C
    Drug Metab Dispos; 1981; 9(6):529-34. PubMed ID: 6120811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.
    Evans GH; Nies AS; Shand DG
    J Pharmacol Exp Ther; 1973 Jul; 186(1):114-22. PubMed ID: 4198771
    [No Abstract]   [Full Text] [Related]  

  • 8. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
    Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
    J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
    Fenyves D; Gariépy L; Villeneuve JP
    Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF; Pichette V; du Souich P
    Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition kinetics of propranolol isomers in the perfused rat liver.
    Hung DY; Siebert GA; Chang P; Anissimov YG; Roberts MS
    J Pharmacol Exp Ther; 2004 Nov; 311(2):822-9. PubMed ID: 15192084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Uptake of propranolol by the isolated perfused rat liver.
    Cohen GM; Davies DS
    Br J Pharmacol; 1974 Mar; 50(3):472P. PubMed ID: 4853880
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    Yu VC; de Lamirande E; Horning MG; Pang KS
    Drug Metab Dispos; 1982; 10(6):568-72. PubMed ID: 6130901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver.
    Vu VT; Chen CP
    Drug Metab Dispos; 1982; 10(4):350-5. PubMed ID: 6126333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of amphotericin B in the isolated perfused rat liver.
    Hong Y; Ramzan I; McLachlan AJ
    J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat.
    Venkataramanan R; Axelson JE
    J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic fate of hexobarbital in the rat.
    Holcomb RR; Gerber N; Bush MT
    J Pharmacol Exp Ther; 1974 Jan; 188(1):15-26. PubMed ID: 4809266
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver.
    Wang Lu LJ; Demetriou SK; Domino EF
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):117-33. PubMed ID: 27150
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.